Pharma Manufacturing

Samsung Biologics’ Plant 5 —?the first facility for its Bio Campus II in Songdo, South Korea — will be operational next month and add “fresh” capacity of 180,000 liters, the company?announced?at its annual general meeting of shareholders. Read more here https://lnkd.in/gNKDkkTi #Samsungbiologics #manufacturingexpansion #pharmanews #pharmamanufacturing

Global contract development and manufacturing organization Recipharm?announced?record-breaking revenue of €827 million for 2024, a 7% year-over-year increase, driven by growth in its biologics business. Read more https://lnkd.in/ghuwgTqq #Recipharm #2024revenue #biologics #CDMO #pharmanews #pharmamanufacturing

Check out this week's Editors' (re)View, where our editors take a closer look at notable happenings in the pharma manufacturing industry. Greg Slabodkin discusses the shortages in the U.S. injectable supply chain and the stakeholders, including Eli Lilly, Merck, Pfizer, Purdue University and The Noramco Group, looking to address it. Read more https://lnkd.in/e-Jmf4BU Eli Lilly and Company #EliLilly #Merck #Pfizer #PurdueUniversity #TheNoramcoGroup #supplychain #injectables #sterileinjectablemanufacturing #injectablemanufacturing #pharmamanufacturing

Vetter is?expanding?its Center for Visual Inspection and Logistics to accommodate increasing demand for the company’s?pharmaceutical filling services. Read more here https://lnkd.in/eArRPZGt Vetter Pharma #VetterPharma #pharmanews #pharmamanufacturing #pharmaceuticalfilling

Almac Group?announced?the opening of an $84 million, 100,000-square-foot commercial manufacturing facility for Almac Pharma Services at its global headquarters in Craigavon, Northern Ireland.? Read more here https://lnkd.in/gZZ6k7rh #AlmacGroup #pharmamanufacturing #pharmanews #manufacturingfacility #commercialmanufacturing

Canada’s Entos Pharmaceuticals has?announced?a $198.5 million project to build an R&D and manufacturing facility in Edmonton, Alberta, backed by $77.5 million in funding from the Canadian and Alberta governments. Read more https://lnkd.in/gZzkFXuF #EntosPharmaceuticals #RandDmanufacturing #RandD #biopharma #biomanufacturing #pharmanews #pharmamanufacturing

As trade tensions escalate between the United States and Canada, Montreal-based biopharma company Theratechnologies Inc. is feeling vulnerable to the potential tariff threats from President Donald Trump and the Canadian government’s retaliatory tariffs on American exports. Read the full article here https://lnkd.in/gATU--X7 #Tradetensions #tariffs #biopharma #tariffthreats #pharmatariffs #pharmamanufacturing

With the right strategies and technologies in place, manufacturers can not only meet the requirements of the proposed BIOSECURE Act but also strengthen their position in an evolving industry. Read the full article here https://lnkd.in/gxbGM_Tp #BIOSECUREact #pharmamanufacturing #pharmamanufacturers #manufacturers #CDMO

Legend Biotech?announced?that it is doubling its manufacturing capacity in 2025 for Carvykti, a CAR-T therapy used to treat relapsed or refractory multiple myeloma Read more https://lnkd.in/grWUvYvE #LegendBiotech #manufacturingcapacity #CARTtherapy #pharmanews #pharmamanufacturing

Exogenus Therapeutics has?partnered?with Lonza to develop a GMP-compliant manufacturing process for Exo-101, the company’s lead exosome-based candidate. Read more here https://lnkd.in/gTHKCeCm #ExogenusTherapeutics #Lonza #pharmanews #pharmamanufacturing